A decade and a half after the approval of mifepristone, there is a lot to celebrate, since many U.S. women now have a choice in the type of abortion they can have. But it is also clear that this drug has been treated differently from other medications, resulting in restrictions that have severely limited its potential to improve access to early abortion.